BioCryst Pharmaceuticals Inc (BCRX): Shares Outstanding
213.06M
As of 2025-12-31
255.26M
As of 2026-06-30
+4.3%
3-year compound annual growth
+3.8%
5-year compound annual growth
+11.3%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 213.06M | +2.2% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 208.54M | +1.3% | 2026-02-26, Balance as of period end |
| 2023-12-31 | 205.77M | +9.5% | 2025-02-25, Balance as of period end |
| 2022-12-31 | 187.91M | +1.9% | 2024-02-27, Balance as of period end |
| 2021-12-31 | 184.35M | +4.2% | 2023-02-27, Balance as of period end |
| 2020-12-31 | 176.88M | +14.8% | 2022-02-28, Balance as of period end |
| 2019-12-31 | 154.08M | +40.0% | 2021-03-01, Balance as of period end |
| 2018-12-31 | 110.06M | +11.8% | 2020-03-13, Balance as of period end |
| 2017-12-31 | 98.41M | +33.4% | 2019-03-14, Balance as of period end |
| 2016-12-31 | 73.78M | +0.6% | 2018-03-12, Balance as of period end |
| 2015-12-31 | 73.36M | +1.9% | 2017-02-27, Balance as of period end |
| 2014-12-31 | 71.95M | +21.8% | 2016-02-26, Balance as of period end |
| 2013-12-31 | 59.09M | +16.1% | 2015-03-02, Balance as of period end |
| 2012-12-31 | 50.89M | +11.5% | 2014-03-10, Balance as of period end |
| 2011-12-31 | 45.66M | +1.6% | 2013-03-11, Balance as of period end |
| 2010-12-31 | 44.96M | n/a | 2012-03-06, Balance as of period end |